XML 242 R95.htm IDEA: XBRL DOCUMENT
v3.25.1

Organization and Nature of Operations - Schedule of Consolidated Financial Statements (Details) |  |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Apr. 06, 2022 | May 08, 2020 | May 18, 2015 | Mar. 31, 2025 | Dec. 31, 2024
Avalon Healthcare System, Inc. (“AHS”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | Delaware May 18, 2015 | Delaware May 18, 2015 |
Percentage of Ownership |  |  | 100.00% | 100.00% | 100.00% |
Principal Activities |  |  |  | Holding company for payroll and other expenses | Holding company for payroll and other expenses |
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | New Jersey February 7, 2017 | New Jersey February 7, 2017 |
Percentage of Ownership |  |  |  | 100.00% | 100.00% |
Principal Activities |  |  |  | Owns and operates an income-producing real property and holds and manages the corporate headquarters | Owns and operates an income-producing real property and holds and manages the corporate headquarters |
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | PRC April 29, 2016 | PRC April 29, 2016 |
Percentage of Ownership |  |  |  | 100.00% | 100.00% |
Principal Activities |  |  |  | Not considered an operating entity | Is not considered an operating entity |
Genexosome Technologies Inc. (“Genexosome”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | Nevada July 31, 2017 | Nevada July 31, 2017 |
Percentage of Ownership |  |  |  | 60.00% | 60.00% |
Principal Activities |  |  |  | No current activities to report; dormant | No current activities to report, dormant |
Avactis Biosciences Inc. (“Avactis”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | Nevada July 18, 2018 | Nevada July 18, 2018 |
Percentage of Ownership | 40.00% | 100.00% |  | 60.00% | 60.00% |
Principal Activities |  |  |  | Dormant; in process of being dissolved | Dormant, is in process of being dissolved |
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | PRC May 8, 2020 | PRC May 8, 2020 |
Percentage of Ownership |  |  |  | 100.00% | 100.00% |
Principal Activities |  |  |  | Dormant; in process of being dissolved | Dormant, is in process of being dissolved |
Avalon Laboratory Services, Inc. (“Avalon Lab”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | Delaware October 14, 2022 | Delaware October 14, 2022 |
Percentage of Ownership |  |  |  | 100.00% | 100.00% |
Principal Activities |  |  |  | No current activities to report; dormant | Laboratory holding company with a 40% membership interest in Lab Services MSO (1) | [1]
Q&A Distribution LLC (“Q&A Distribution”) [Member] |  |  |  |  |  |
Schedule of Consolidated Financial Statements [Line Items] |  |  |  |  |  |
Place and Date of Incorporation |  |  |  | Texas May 1, 2024 | Texas May 1, 2024 |
Percentage of Ownership |  |  |  | 100.00% | 100.00% |
Principal Activities |  |  |  | Distributes KetoAir device | Distributes KetoAir device |
[1] | On February 26, 2025, the Company and Lab Services MSO entered into a Redemption and Abandonment Agreement, whereby Lab Services MSO redeemed the 40% equity interest in Lab Services MSO held by the Company.

X
- Definition The equity method investment place and date of incorporation. + References No definition available. + Details
Name: | avco_EquityMethodInvestmentPlaceAndDateOfIncorporation
Namespace Prefix: | avco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of business purpose of the subsidiary of the limited liability company or limited partnership, for example, its day-to-day operating functions and whether it acts as a holding or operating company. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonHealthcareSystemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonRT9PropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonShanghaiHealthcareTechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_GenExosomeTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisNanjingBiosciencesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonLaboratoryServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_QADistributionLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |